Literature DB >> 21978991

A kinase-anchoring proteins and adenylyl cyclase in cardiovascular physiology and pathology.

Riad Efendiev1, Carmen W Dessauer.   

Abstract

3'-5'-Cyclic adenosine monophosphate (cAMP), generated by adenylyl cyclase (AC), serves as a second messenger in signaling pathways regulating many aspects of cardiac physiology, including contraction rate and action potential duration, and in the pathophysiology of hypertrophy and heart failure. A kinase-anchoring proteins localize the effect of cAMP in space and time by organizing receptors, AC, protein kinase A, and other components of the cAMP cascade into multiprotein complexes. In this review, we discuss how the interaction of A kinase-anchoring proteins with distinct AC isoforms affects cardiovascular physiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21978991      PMCID: PMC3191934          DOI: 10.1097/FJC.0b013e31821bc3f0

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  73 in total

1.  Adenylyl cyclase and G protein receptor kinase expression during development of heart failure.

Authors:  P Ping; T Anzai; M Gao; H K Hammond
Journal:  Am J Physiol       Date:  1997-08

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

3.  Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload.

Authors:  Aziz Guellich; Shumin Gao; Chull Hong; Lin Yan; Thomas E Wagner; Sunil K Dhar; Bijan Ghaleh; Luc Hittinger; Kosaku Iwatsubo; Yoshihiro Ishikawa; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-18       Impact factor: 4.733

4.  The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3.

Authors:  Cecile Terrenoire; Miles D Houslay; George S Baillie; Robert S Kass
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

5.  Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice.

Authors:  Tong Tang; N Chin Lai; H Kirk Hammond; David M Roth; Yuan Yang; Tracy Guo; Mei Hua Gao
Journal:  J Am Coll Cardiol       Date:  2010-04-06       Impact factor: 24.094

6.  Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a.

Authors:  C L Antos; N Frey; S O Marx; S Reiken; M Gaburjakova; J A Richardson; A R Marks; E N Olson
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

7.  Localized Na+/H+ exchanger 1 expression protects Ca2+-regulated adenylyl cyclases from changes in intracellular pH.

Authors:  Debbie Willoughby; Nanako Masada; Andrew J Crossthwaite; Antonio Ciruela; Dermot M F Cooper
Journal:  J Biol Chem       Date:  2005-07-07       Impact factor: 5.157

8.  Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart.

Authors:  Yasuo Sugano; N Chin Lai; Mei Hua Gao; Amy L Firth; Jason X-J Yuan; Wilbur Y W Lew; H Kirk Hammond
Journal:  Biochem Biophys Res Commun       Date:  2010-12-30       Impact factor: 3.575

9.  Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes.

Authors:  M Gao; P Ping; S Post; P A Insel; R Tang; H K Hammond
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

10.  Mutation of an A-kinase-anchoring protein causes long-QT syndrome.

Authors:  Lei Chen; Michelle L Marquardt; David J Tester; Kevin J Sampson; Michael J Ackerman; Robert S Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

View more
  15 in total

Review 1.  Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps.

Authors:  Rennolds S Ostrom; Amy S Bogard; Robert Gros; Ross D Feldman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-20       Impact factor: 3.000

2.  Compartmentalized cAMP responses to prostaglandin EP2 receptor activation in human airway smooth muscle cells.

Authors:  Shailesh R Agarwal; Kathryn Miyashiro; Htun Latt; Rennolds S Ostrom; Robert D Harvey
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

Review 3.  cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes.

Authors:  Timothy B Johnstone; Shailesh R Agarwal; Robert D Harvey; Rennolds S Ostrom
Journal:  Mol Pharmacol       Date:  2017-12-07       Impact factor: 4.436

4.  Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.

Authors:  Cameron S Brand; Harrison J Hocker; Alemayehu A Gorfe; Claudio N Cavasotto; Carmen W Dessauer
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

5.  Adenylyl cyclase 2 selectively couples to E prostanoid type 2 receptors, whereas adenylyl cyclase 3 is not receptor-regulated in airway smooth muscle.

Authors:  Amy S Bogard; Piyatilake Adris; Rennolds S Ostrom
Journal:  J Pharmacol Exp Ther       Date:  2012-05-22       Impact factor: 4.030

Review 6.  Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging.

Authors:  Stephen F Vatner; Misun Park; Lin Yan; Grace J Lee; Lo Lai; Kousaku Iwatsubo; Yoshihiro Ishikawa; Jeffrey Pessin; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-26       Impact factor: 4.733

Review 7.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

8.  Mechanisms that match ATP supply to demand in cardiac pacemaker cells during high ATP demand.

Authors:  Yael Yaniv; Harold A Spurgeon; Bruce D Ziman; Alexey E Lyashkov; Edward G Lakatta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

9.  Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment.

Authors:  Stephanie J Nakano; Juliana Sucharov; Robert van Dusen; Mackenzie Cecil; Karin Nunley; Sean Wickers; Anis Karimpur-Fard; Brian L Stauffer; Shelley D Miyamoto; Carmen C Sucharov
Journal:  J Card Fail       Date:  2016-07-15       Impact factor: 5.712

Review 10.  Cardiac cAMP: production, hydrolysis, modulation and detection.

Authors:  Cédric Boularan; Céline Gales
Journal:  Front Pharmacol       Date:  2015-10-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.